Jane J. Zara

Array ( [id] => 6635298 [patent_doc_number] => 20030211606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Antisense modulation of DYRK4 expression' [patent_app_type] => new [patent_app_number] => 10/144140 [patent_app_country] => US [patent_app_date] => 2002-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28629 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20030211606.pdf [firstpage_image] =>[orig_patent_app_number] => 10144140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6721550 [patent_doc_number] => 20030055240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'HPV specific oligonucleotides' [patent_app_type] => new [patent_app_number] => 10/136427 [patent_app_country] => US [patent_app_date] => 2002-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16438 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20030055240.pdf [firstpage_image] =>[orig_patent_app_number] => 10136427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6735470 [patent_doc_number] => 20030013105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'Methods for identifying drugs specific for known molecular targets using model compounds specific for the molecular targets' [patent_app_type] => new [patent_app_number] => 10/136190 [patent_app_country] => US [patent_app_date] => 2002-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8852 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20030013105.pdf [firstpage_image] =>[orig_patent_app_number] => 10136190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6654156 [patent_doc_number] => 20030077279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Methods for treating vascular disease by inhibiting toll-like receptor-4' [patent_app_type] => new [patent_app_number] => 10/128166 [patent_app_country] => US [patent_app_date] => 2002-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9010 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20030077279.pdf [firstpage_image] =>[orig_patent_app_number] => 10128166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6261870 [patent_doc_number] => 20020187954 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-12 [patent_title] => 'Insulin-like growth factor II antisense oligonucleotide sequences and methods of using same to modulate cell growth' [patent_app_type] => new [patent_app_number] => 10/125181 [patent_app_country] => US [patent_app_date] => 2002-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 13140 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20020187954.pdf [firstpage_image] =>[orig_patent_app_number] => 10125181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6751177 [patent_doc_number] => 20030045698 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Compounds, processes and intermediates for synthesis of mixed backbone oligomeric compounds' [patent_app_type] => new [patent_app_number] => 10/117267 [patent_app_country] => US [patent_app_date] => 2002-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12785 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20030045698.pdf [firstpage_image] =>[orig_patent_app_number] => 10117267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7276314 [patent_doc_number] => 20040235765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Lps-responsive chs1/beige-like anchor gene and therapeutic applications thereof' [patent_app_type] => new [patent_app_number] => 10/473741 [patent_app_country] => US [patent_app_date] => 2004-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 24641 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235765.pdf [firstpage_image] =>[orig_patent_app_number] => 10473741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 645435 [patent_doc_number] => 07119078 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-10 [patent_title] => 'Technology of intracellular delivery of DNA oligonucleotides to improve drug activity' [patent_app_type] => utility [patent_app_number] => 10/107746 [patent_app_country] => US [patent_app_date] => 2002-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 14 [patent_no_of_words] => 18072 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/119/07119078.pdf [firstpage_image] =>[orig_patent_app_number] => 10107746 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6177844 [patent_doc_number] => 20020156044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Use of EXT genes for the treatment of cancer and other diseases' [patent_app_type] => new [patent_app_number] => 10/106092 [patent_app_country] => US [patent_app_date] => 2002-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 11151 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20020156044.pdf [firstpage_image] =>[orig_patent_app_number] => 10106092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6729639 [patent_doc_number] => 20030185829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Jagged 2 inhibitors for inducing apoptosis' [patent_app_type] => new [patent_app_number] => 10/096399 [patent_app_country] => US [patent_app_date] => 2002-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27360 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20030185829.pdf [firstpage_image] =>[orig_patent_app_number] => 10096399 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6536277 [patent_doc_number] => 20020193307 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Antagonism of endothelin actions' [patent_app_type] => new [patent_app_number] => 10/097206 [patent_app_country] => US [patent_app_date] => 2002-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7421 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20020193307.pdf [firstpage_image] =>[orig_patent_app_number] => 10097206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6783502 [patent_doc_number] => 20030064950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-03 [patent_title] => 'Methods for reducing body fat and increasing lean body mass by reducing stearoyl-CoA desaturase 1 activity' [patent_app_type] => new [patent_app_number] => 10/094841 [patent_app_country] => US [patent_app_date] => 2002-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15628 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20030064950.pdf [firstpage_image] =>[orig_patent_app_number] => 10094841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6715909 [patent_doc_number] => 20030027257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-06 [patent_title] => 'Sequences for improving the efficiency of secretion of non-secreted protein from mammalian and insect cells' [patent_app_type] => new [patent_app_number] => 10/083590 [patent_app_country] => US [patent_app_date] => 2002-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8906 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20030027257.pdf [firstpage_image] =>[orig_patent_app_number] => 10083590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 435916 [patent_doc_number] => 07262173 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-28 [patent_title] => 'Chemosensitizing with liposomes containing oligonucleotides' [patent_app_type] => utility [patent_app_number] => 10/075994 [patent_app_country] => US [patent_app_date] => 2002-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 27 [patent_no_of_words] => 19096 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/262/07262173.pdf [firstpage_image] =>[orig_patent_app_number] => 10075994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 507950 [patent_doc_number] => 07198911 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-03 [patent_title] => 'Identification and cloning of a novel human gene, RET16, involved in the intracellular signaling cascade' [patent_app_type] => utility [patent_app_number] => 10/077111 [patent_app_country] => US [patent_app_date] => 2002-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 32 [patent_no_of_words] => 33387 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/198/07198911.pdf [firstpage_image] =>[orig_patent_app_number] => 10077111 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6736038 [patent_doc_number] => 20030013673 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'Modulating the Rad-nm23 interaction' [patent_app_type] => new [patent_app_number] => 10/074694 [patent_app_country] => US [patent_app_date] => 2002-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13598 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20030013673.pdf [firstpage_image] =>[orig_patent_app_number] => 10074694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1063282 [patent_doc_number] => 06849725 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-02-01 [patent_title] => 'Covalently closed nucleic acid molecules for immunostimulation' [patent_app_type] => utility [patent_app_number] => 10/057311 [patent_app_country] => US [patent_app_date] => 2002-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8336 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/849/06849725.pdf [firstpage_image] =>[orig_patent_app_number] => 10057311 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6622253 [patent_doc_number] => 20020065243 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-30 [patent_title] => 'Methods to enhance and confine expression of genes' [patent_app_type] => new [patent_app_number] => 10/051345 [patent_app_country] => US [patent_app_date] => 2002-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11852 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20020065243.pdf [firstpage_image] =>[orig_patent_app_number] => 10051345 [rel_patent_id] =>[rel_patent_doc_number] =>)